Solitary Extramedullary Plasmacytoma of the Larynx and Secondary Laryngeal Involvement in Plasma Cell Myeloma: Single-Centre Retrospective Analysis and Systematic Literature Review
Authors:
- Elżbieta SzczepanekESElżbieta Szczepanek
- Joanna Drozd-SokołowskaJDJoanna Drozd-Sokołowska
- Jacek SokołowskiJSJacek Sokołowski
- Anna RzepakowskaARAnna Rzepakowska
- Arkadiusz MoskwaAMArkadiusz Moskwa
- Jakub PachlaJPJakub Pachla
- Jakub GrzybowskiJGJakub Grzybowski
- Katarzyna WoźnicaKWKatarzyna Woźnica
- Kazimierz NiemczykKNKazimierz Niemczyk
- Krzysztof JamroziakKJKrzysztof Jamroziak
Open Access
- 28 July 2022
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (15) , 4390
Abstract
The involvement of the larynx in plasma cell myeloma (PCM) may manifest as solitary extramedullary plasmacytoma of the larynx (sEMP-L) or as infiltration of the larynx during newly diagnosed or relapsed systemic disease with bone marrow involvement (plasma cell myeloma with laryngeal involvement, PCM-L). To increase knowledge about these rare conditions, we performed a retrospective analysis along with a comprehensive literature review of cases of sEMP-L or PCM-L. Six patients (two sEMP-L and four PCM-L) were identified in our tertiary laryngological centre from 2009 to 2021, constituting 0.88% of all malignant laryngeal tumours. The literature search yielded 187 cases, including 152 sEMP-L and 35 sPCM-L. A comparison of baseline characteristics between sEMP-L and PCM-L performed in the combined cohort of cases from literature review and retrospective analysis revealed that patients with sEMP-L were younger (56 vs. 64 years, p ≤ 0.001) and presented less commonly with thyroid or cricoid cartilage involvement (2.2% vs. 30.8%, p ≤ 0.001). The prognosis of sEMP-L was better than PCM-L (overall survival 86% vs. 55% at 5 years, p = 0.002). Analysis of potential factors that could influence progression-free survival (PFS) in the group of sEMP-L revealed that male sex and cartilage involvement negatively affected PFS in univariate analyses, while only cartilage involvement retained statistical significance in multivariate analysis (HR = 19.94, p = 0.024). In conclusion, PCM with laryngeal involvement is sporadic. Secondary involvement of the larynx during PCM might be more common than sEMP-L and is associated with worse survival. The involvement of cartilage adversely influences the outcome of sEMP-L.Keywords
This publication has 157 references indexed in Scilit:
- Extramedullary relapse of multiple myeloma in the thyroid cartilageBMJ Case Reports, 2013
- Laryngeal Involvement of Multiple MyelomaCase Reports in Oncological Medicine, 2012
- Extramedullary Plasmacytoma of the Larynx: A Case Report of Subglottic LocalizationCase Reports in Otolaryngology, 2012
- Extramedullary plasmacytoma of the larynxInternational Archives of Otorhinolaryngology, 2012
- Solitary Extramedullary Plasmacytoma of the Apex of Arytenoid: Endoscopic, CT, and Pathologic FindingsClinical and Experimental Otorhinolaryngology, 2012
- Extramedullary Relapse in a Case of Multiple Myeloma Involving the Thyroid Cartilage: Case Report and Review of LiteratureIndian Journal of Surgical Oncology, 2011
- Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patientsAnnals of Oncology, 2009
- Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumBlood, 2008
- CorrespondenceEuropean Journal of Cancer, 1998
- Disseminated extramedullary plasmacytomasJournal of the American Academy of Dermatology, 1986